- Home
- TXMD vs TIRX Comparison
TXMD vs TIRX Comparison
Compare TXMD & TIRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXMD
- TIRX
- Stock Information
- Founded
- TXMD 2008
- TIRX 2010
- Country
- TXMD United States
- TIRX China
- Employees
- TXMD N/A
- TIRX N/A
- Industry
- TXMD Biotechnology: Pharmaceutical Preparations
- TIRX Specialty Insurers
- Sector
- TXMD Health Care
- TIRX Finance
- Exchange
- TXMD Nasdaq
- TIRX Nasdaq
- Market Cap
- TXMD 17.1M
- TIRX 14.0M
- IPO Year
- TXMD N/A
- TIRX 2021
- Fundamental
- Price
- TXMD $1.09
- TIRX $1.26
- Analyst Decision
- TXMD
- TIRX
- Analyst Count
- TXMD 0
- TIRX 0
- Target Price
- TXMD N/A
- TIRX N/A
- AVG Volume (30 Days)
- TXMD 66.5K
- TIRX 1.2M
- Earning Date
- TXMD 08-11-2025
- TIRX 08-15-2025
- Dividend Yield
- TXMD N/A
- TIRX N/A
- EPS Growth
- TXMD N/A
- TIRX N/A
- EPS
- TXMD N/A
- TIRX N/A
- Revenue
- TXMD $1,841,000.00
- TIRX $3,219,336.00
- Revenue This Year
- TXMD $427.09
- TIRX N/A
- Revenue Next Year
- TXMD N/A
- TIRX N/A
- P/E Ratio
- TXMD N/A
- TIRX N/A
- Revenue Growth
- TXMD 53.55
- TIRX 158.74
- 52 Week Low
- TXMD $0.70
- TIRX $1.07
- 52 Week High
- TXMD $2.44
- TIRX $4.15
- Technical
- Relative Strength Index (RSI)
- TXMD 38.09
- TIRX 42.23
- Support Level
- TXMD $1.07
- TIRX $1.25
- Resistance Level
- TXMD $1.22
- TIRX $1.45
- Average True Range (ATR)
- TXMD 0.13
- TIRX 0.12
- MACD
- TXMD -0.02
- TIRX -0.02
- Stochastic Oscillator
- TXMD 19.15
- TIRX 2.22
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
About TIRX TIAN RUIXIANG Holdings Ltd
Tian Ruixiang Holdings Ltd is an Insurance Brokerage firm. It distributes a wide range of insurance products, which are categorized into two groups; property and casualty insurance, such as commercial property insurance, liability insurance, accidental insurance, and automobile insurance; and other insurances, such as health insurance, life insurance, and miscellaneous insurances. It also generates a small amount of revenue from risk management services. The firm act on behalf of its customers seeking insurance coverage from insurance companies. It generates revenue from the provision of insurance brokerage services.